Get started
Author

Anne Karin Lindahl

Observed names: A K Lindahl, A. K. Lindahl, A.-K. Lindahl, A.K Lindahl, A.K. Lindahl, Anne Lindahl, Lindahl, Anne Karin
Observed institutions: Oslo University Hospital, University Hospital of North Norway, Norwegian Institute of Public Health, BI Norwegian Business School, University of Oslo, Akershus University Hospital, Ghent University Hospital, Nasjonalt Kunnskapssenter for Helsetjenesten, St Mary's Hospital, University of Bergen
ORCID: 0000-0001-5148-0639
Observed ORCID: 0000-0001-5148-0639
OpenAlex ID: A5103803131
Editor's Choice – Management of Atherosclerotic Carotid and Vertebral Artery Disease: 2017 Clinical Practice Guidelines of the European Society for Vascular Surgery (ESVS)
2017 · A.R. Naylor, J.-B. Ricco, et al. · European Journal of Vascular and Endovascular Surgery · 1,162
PDF
Paying for performance to improve the delivery of health interventions in low- and middle-income countries
2012 · Sophie Witter, Atle Fretheim, et al. · Cochrane Database of Systematic Reviews · 365
Towards actionable international comparisons of health system performance: expert revision of the OECD framework and quality indicators
2015 · F. Carinci, K. Van Gool, et al. · International Journal for Quality in Health Care · 353
PDF
Leadership and governance in seven developed health systems
2012 · Peter C. Smith, Anders Anell, et al. · Health Policy · 172
The present status of tissue factor pathway inhibitor
1992 · A. K. Lindahl, P. M. Sandset, et al. · Blood Coagulation & Fibrinolysis · 115
The Oslo Balloon Angioplasty versus Conservative Treatment Study (OBACT)—The 2-years Results of a Single Centre, Prospective, Randomised Study in Patients with Intermittent Claudication
2006 · M. Nylænde, M. Abdelnoor, et al. · European Journal of Vascular and Endovascular Surgery · 79
PDF
Increased Plasma Thrombomodulin in Cancer Patients
1993 · Anne Karin Lindahl, Marie-Claire Boffa, et al. · Thrombosis and Haemostasis · 63
The anticoagulant effect in heparinized blood and plasma resulting from interactions with extrinsic pathway inhibitor
1991 · Anne Karin Lindahl, Ulrich Abildgaard, et al. · Thrombosis Research · 54
Release of extrinsic pathway inhibitor after heparin injection: Increased response in cancer patients
1990 · Anne Karin Lindahl, Ulrich Abildgaard, et al. · Thrombosis Research · 48
Elevated plasma levels of the factor Xa–TFPI complex in cancer patients
2002 · Nina Iversen, Anne Karin Lindahl, et al. · Thrombosis Research · 45
Heparin Requires both Antithrombin and Extrinsic Pathway Inhibitor for Its Anticoagulant Effect in Human Blood
2009 · Ulrich Abildgaard, Anne Karin Lindahl, et al. · Haemostasis · 41
Validity of an Exam Assessment in Surgical Skill: EBSQ-VASC Pilot Study
2004 · V.A Pandey, J.H.N Wolfe, et al. · European Journal of Vascular and Endovascular Surgery · 41
PDF
Performance-based financing in low- and middle-income countries: still more questions than answers
2012 · Atle Fretheim, Sophie Witter, et al. · Bulletin of the World Health Organization · 38
PDF
Patient experiences questionnaire for interdisciplinary treatment for substance dependence (PEQ-ITSD): reliability and validity following a national survey in Norway
2017 · Mona Haugum, Hilde Hestad Iversen, et al. · BMC Psychiatry · 32
PDF
Extrinsic pathway inhibitor (EPI) and the post-heparin anticoagulant effect in tissue thromboplastin induced coagulation
1991 · Anne Karin Lindahl, Ulrich Abildgaard, et al. · Thrombosis Research · 32
What is Good Quality of Health Care?
2015 · Magne Nylenna, Øyvind Andresen Bjertnaes, et al. · Professions and Professionalism · 31
PDF
Undiagnosed dysglycaemia and inflammation in cardiovascular disease
2006 · O. E. Johansen, K. I. Birkeland, et al. · European Journal of Clinical Investigation · 30
PDF
Coagulation inhibition and activation in pancreatic cancer. Changes during progress of disease
1992 · Anne Karin Lindahl, Ole Rasmus Ødegaard, et al. · Cancer · 28
Extrinsic pathway inhibitor (EPI) released to the blood by heparin is a more powerful coagulation inhibitor than is recombinant EPI
1991 · Anne Karin Lindahl, Ulrich Abildgaard, et al. · Thrombosis Research · 25
Norway: Health system review. Health Systems in Transition
2014 · Ånen Ringard, Anna Sagan, et al. · NORA - Norwegian Open Research Archives · 24
PDF
Indices of Hypercoagulation in Cancer as Compared with Those in Acute Inflammation and Acute Infarction
2009 · Anne Karin Lindahl, Per Morten Sandset, et al. · Haemostasis · 24
The Patient-Reported Incident in Hospital Instrument (PRIH-I): assessments of data quality, test–retest reliability and hospital-level reliability
2013 · Oyvind Bjertnaes, Kjersti Eeg Skudal, et al. · BMJ Quality & Safety · 22
PDF
Tissue factor pathway inhibitor prevents thrombus formation on procoagulant subendothelial matrix
1994 · A K Lindahl, P M Sandset, et al. · Blood Coagulation & Fibrinolysis · 22
Effect of Tissue Factor Pathway Inhibitor (TFPI) in the HEPTEST® Assay and in an Amidolytic Anti Factor Xa Assay for LMW Heparin
1992 · Hanne I Kristensen, Per B Østergaard, et al. · Thrombosis and Haemostasis · 20
Prothrombotic activity is associated with the anatomical as well as the functional severity of peripheral arterial occlusive disease
2006 · Andries Kroese, Einar Stranden, et al. · Thrombosis and Haemostasis · 19
Works count: 121
Citation count: 3,101
H-index: 22
I10-index: 35
Year
Topic
Type